Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Project Grant

University of Toronto

$100,000.00

A census of endocrine disrupting chemicals binding to nuclear receptors

EF 2023-24

Résumé
The incidence of endocrine disorders (e.g., obesity) and cancers has rapidly increased over the last three decades, becoming a worldwide health concern. The growing human exposure to endocrine disrupting chemicals (EDCs) has long been hypothesized as a critical driving factor. However, the exact EDCs causing health impacts remain unknown, mainly due to the immense number of manufactured chemicals (>350,000) co-occurring as a 'chemical cocktail'. Only ~1% of the EDC bioactivities of the 'chemical cocktails' have been explained while the majority of EDCs remain unknown. We hypothesize that a family of proteins called nuclear receptors are the master regulators of EDC effects, and a systematic identification of their ligands will largely clarify the adverse health impacts of EDCs. Our approach for testing this hypothesis includes the generation 48 His-tagged human nuclear receptor proteins to isolate EDCs physically binding to nuclear receptors, from human blood and house dust samples at the exposome-wide level. The structures of isolated EDCs will be annotated using high-resolution mass spectrometry or nuclear magnetic resonance. The identified EDCs will be purchased or synthesized to characterize their binding to nuclear receptors using an array of biophysics assays including isothermal titration calorimetry and X-ray crystallography. We will focus primarily on a limited number of selected EDCs (e.g., hydrocarbon sulfonates) to further investigate their obesogenic and other EDC effects in mouse models. In parallel, the full list of identified EDCs and their mass spectra will be deposited to an open-access repository. The systematic identification of new EDCs will provide a major leap forward in our understanding the contributions of EDCs exposure to the increasing incidence of endocrine disorders and cancers.
Programme
Project Grant
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
487142
Name
Peng Hui
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Human Development, Child and Youth Health
Theme2
Biomedical
Prcname2
Pharmacology & Toxicology
Projecttitle
A census of endocrine disrupting chemicals binding to nuclear receptors
Programtype2
Operating Grants
Orgnameinp2
University of Toronto
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Biophysics; Endocrine Disrupting Chemicals; In Vitro And In Vivo Toxicity; Mass Spectrometry; Nuclear Receptors; Obesity; Ppar; Protein Affinity Purification
Abstract
The incidence of endocrine disorders (e.g., obesity) and cancers has rapidly increased over the last three decades, becoming a worldwide health concern. The growing human exposure to endocrine disrupting chemicals (EDCs) has long been hypothesized as a critical driving factor. However, the exact EDCs causing health impacts remain unknown, mainly due to the immense number of manufactured chemicals (>350,000) co-occurring as a 'chemical cocktail'. Only ~1% of the EDC bioactivities of the 'chemical cocktails' have been explained while the majority of EDCs remain unknown. We hypothesize that a family of proteins called nuclear receptors are the master regulators of EDC effects, and a systematic identification of their ligands will largely clarify the adverse health impacts of EDCs. Our approach for testing this hypothesis includes the generation 48 His-tagged human nuclear receptor proteins to isolate EDCs physically binding to nuclear receptors, from human blood and house dust samples at the exposome-wide level. The structures of isolated EDCs will be annotated using high-resolution mass spectrometry or nuclear magnetic resonance. The identified EDCs will be purchased or synthesized to characterize their binding to nuclear receptors using an array of biophysics assays including isothermal titration calorimetry and X-ray crystallography. We will focus primarily on a limited number of selected EDCs (e.g., hydrocarbon sulfonates) to further investigate their obesogenic and other EDC effects in mouse models. In parallel, the full list of identified EDCs and their mass spectra will be deposited to an open-access repository. The systematic identification of new EDCs will provide a major leap forward in our understanding the contributions of EDCs exposure to the increasing incidence of endocrine disorders and cancers.
Competitiondate
202304
Approvedterm2
1 yr 0 mth
Pinamesdelim
Peng, Hui
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~